Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet abnormalities in myeloproliferative disorders.

S Holme1, S Murphy

  • 1American Red Cross Blood Services, Tidewater Region, Norfolk, Virginia.

Clinics in Laboratory Medicine
|December 1, 1990
PubMed
Summary

Platelet abnormalities in myeloproliferative neoplasms (MPN) are common but primarily diagnostic. These platelet defects do not predict clinical outcomes or disease progression in MPN patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The "Chimney approach" for transcatheter aortic valve implantation: A strategy for trans axillarian bareback approach in patients with no other access options.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2015
Same author

In vitro storage characteristics of platelet concentrates suspended in 70% SSP+(TM) additive solution versus plasma over a 14-day storage period.

Vox sanguinis·2011
Same author

Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma.

Vox sanguinis·2009
Same author

Platelet counts in pools of platelet-rich plasma-derived platelet concentrates.

Vox sanguinis·2005
Same author

The use of a bacteria detection system to evaluate bacterial contamination in PLT concentrates.

Transfusion·2004
Same author

In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter.

Transfusion·2001

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Myeloproliferative neoplasms (MPN) are characterized by various platelet abnormalities.
  • These platelet defects are primarily used for diagnostic purposes in MPN.
  • Their predictive value for clinical manifestations or disease progression is limited.

Purpose of the Study:

  • To review the diagnostic significance of platelet abnormalities in MPN.
  • To discuss the limited predictive value of these abnormalities for clinical outcomes.
  • To explore the potential origins and modifications of these platelet defects.

Main Methods:

  • Review of existing literature on platelet abnormalities in MPN.
  • Analysis of reported platelet characteristics and their correlation with clinical data.
  • Discussion of potential pathogenetic mechanisms at the megakaryocyte level and post-release modifications.

Main Results:

  • Consistent defects include decreased serotonin and adenine nucleotides, reduced platelet density, abnormal ultrastructure (paucity of granules, hypertrophied canicular system), altered glycoprotein profile (reduced GPIb), and diminished lipoxygenase activity and aggregation response.
  • These abnormalities may originate from megakaryocyte defects.
  • Platelet characteristics can be further modified by thrombosis, aging, disease progression, or treatment.

Conclusions:

  • Platelet abnormalities in MPN are diagnostically relevant but lack significant predictive value for disease course or clinical events.
  • The observed paradoxical relationship between bleeding/thrombosis and platelet function tests may be explained by these multifaceted origins and modifications.
  • Further research may elucidate the precise role of these platelet defects in MPN pathogenesis and clinical management.

Related Experiment Videos